Though Qiagen has in-licensed technology that would enable it to develop its own microarrays, it has decided to pursue supply agreements with companies already in that field, a company spokesperson told BioCommerce Week.

Last week, Qiagen signed a supply pact with its second microarray partner, Osmetech, under which Osmetech will incorporate Qiagen's preanalytical consumables and technologies into its microarray products for research and in vitro diagnostic applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.